Loading...
Latrepirdine for Alzheimer's disease
BACKGROUND: Current treatments for Alzheimer’s disease (AD) provide modest symptomatic relief but do not slow the progression of the disease. Latrepirdine may modulate several targets involved in AD pathology, including lipid peroxidation, mitochondrial permeability, voltage‐gated calcium ion channe...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2015
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388906/ https://ncbi.nlm.nih.gov/pubmed/25897825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009524.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|